0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
China Anti-Venom Market Report & Forecast 2021-2027
Published Date: October 2021
|
Report Code: QYRE-Auto-21V5558
Home | Market Reports | Business & Industrial | Business Services
China Anti Venom Market Report Forecast 2021 2027

China Anti-Venom Market Report & Forecast 2021-2027

Code: QYRE-Auto-21V5558
Report
October 2021
92 Pages
QYResearch
Region: Global, China,
Description
Table of Content
Tables & Figures
China Anti-Venom Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Vials)
China Anti-Venom Market Segment Percentages, By Type, 2020 (%)
Polyvalent Anti-Venom
Monovalent Anti-Venom
China Anti-Venom Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Vials)
China Anti-Venom Market Segment Percentages, By Application, 2020 (%)
Non-profit Institutions
Hospitals and Clinic
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Anti-Venom revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Anti-Venom revenues share in China market, 2020 (%)
Key companies Anti-Venom sales in China market, 2016-2021 (Estimated), (K Vials)
Key companies Anti-Venom sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
1 Introduction to Research & Analysis Reports
1.1 Anti-Venom Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Anti-Venom Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Anti-Venom Overall Market Size
2.1 China Anti-Venom Market Size: 2021 VS 2027
2.2 China Anti-Venom Revenue, Prospects & Forecasts: 2016-2027
2.3 China Anti-Venom Sales: 2016-2027
3 Company Landscape
3.1 Top Anti-Venom Players in China Market
3.2 Top China Anti-Venom Companies Ranked by Revenue
3.3 China Anti-Venom Revenue by Companies
3.4 China Anti-Venom Sales by Companies
3.5 China Anti-Venom Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Anti-Venom Companies in China Market, by Revenue in 2020
3.7 Manufacturers Anti-Venom Product Type
3.8 Tier 1, Tier 2 and Tier 3 Anti-Venom Players in China Market
3.8.1 List of Tier 1 Anti-Venom Companies in China
3.8.2 List of Tier 2 and Tier 3 Anti-Venom Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Anti-Venom Market Size Markets, 2021 & 2027
4.1.2 Polyvalent Anti-Venom
4.1.3 Monovalent Anti-Venom
4.2 By Type - China Anti-Venom Revenue & Forecasts
4.2.1 By Type - China Anti-Venom Revenue, 2016-2021
4.2.2 By Type - China Anti-Venom Revenue, 2022-2027
4.2.3 By Type - China Anti-Venom Revenue Market Share, 2016-2027
4.3 By Type - China Anti-Venom Sales & Forecasts
4.3.1 By Type - China Anti-Venom Sales, 2016-2021
4.3.2 By Type - China Anti-Venom Sales, 2022-2027
4.3.3 By Type - China Anti-Venom Sales Market Share, 2016-2027
4.4 By Type - China Anti-Venom Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Anti-Venom Market Size, 2021 & 2027
5.1.2 Non-profit Institutions
5.1.3 Hospitals and Clinic
5.2 By Application - China Anti-Venom Revenue & Forecasts
5.2.1 By Application - China Anti-Venom Revenue, 2016-2021
5.2.2 By Application - China Anti-Venom Revenue, 2022-2027
5.2.3 By Application - China Anti-Venom Revenue Market Share, 2016-2027
5.3 By Application - China Anti-Venom Sales & Forecasts
5.3.1 By Application - China Anti-Venom Sales, 2016-2021
5.3.2 By Application - China Anti-Venom Sales, 2022-2027
5.3.3 By Application - China Anti-Venom Sales Market Share, 2016-2027
5.4 By Application - China Anti-Venom Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Overview
6.1.3 CSL Anti-Venom Sales and Revenue in China Market (2016-2021)
6.1.4 CSL Anti-Venom Product Description
6.1.5 CSL Recent Developments
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Overview
6.2.3 Merck Anti-Venom Sales and Revenue in China Market (2016-2021)
6.2.4 Merck Anti-Venom Product Description
6.2.5 Merck Recent Developments
6.3 BTG
6.3.1 BTG Corporation Information
6.3.2 BTG Overview
6.3.3 BTG Anti-Venom Sales and Revenue in China Market (2016-2021)
6.3.4 BTG Anti-Venom Product Description
6.3.5 BTG Recent Developments
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Overview
6.4.3 Pfizer Anti-Venom Sales and Revenue in China Market (2016-2021)
6.4.4 Pfizer Anti-Venom Product Description
6.4.5 Pfizer Recent Developments
6.5 Haffkine Bio-Pharmaceutical
6.5.1 Haffkine Bio-Pharmaceutical Corporation Information
6.5.2 Haffkine Bio-Pharmaceutical Overview
6.5.3 Haffkine Bio-Pharmaceutical Anti-Venom Sales and Revenue in China Market (2016-2021)
6.5.4 Haffkine Bio-Pharmaceutical Anti-Venom Product Description
6.5.5 Haffkine Bio-Pharmaceutical Recent Developments
6.6 Rare Disease Therapeutics
6.6.1 Rare Disease Therapeutics Corporation Information
6.6.2 Rare Disease Therapeutics Overview
6.6.3 Rare Disease Therapeutics Anti-Venom Sales and Revenue in China Market (2016-2021)
6.6.4 Rare Disease Therapeutics Anti-Venom Product Description
6.6.5 Rare Disease Therapeutics Recent Developments
6.7 Flynn Pharma
6.7.1 Flynn Pharma Corporation Information
6.7.2 Flynn Pharma Overview
6.7.3 Flynn Pharma Anti-Venom Sales and Revenue in China Market (2016-2021)
6.7.4 Flynn Pharma Anti-Venom Product Description
6.7.5 Flynn Pharma Recent Developments
6.8 Vins Bioproducts
6.8.1 Vins Bioproducts Corporation Information
6.8.2 Vins Bioproducts Overview
6.8.3 Vins Bioproducts Anti-Venom Sales and Revenue in China Market (2016-2021)
6.8.4 Vins Bioproducts Anti-Venom Product Description
6.8.5 Vins Bioproducts Recent Developments
6.9 Bharat Serums and Vaccines
6.9.1 Bharat Serums and Vaccines Corporation Information
6.9.2 Bharat Serums and Vaccines Overview
6.9.3 Bharat Serums and Vaccines Anti-Venom Sales and Revenue in China Market (2016-2021)
6.9.4 Bharat Serums and Vaccines Anti-Venom Product Description
6.9.5 Bharat Serums and Vaccines Recent Developments
6.10 Serum Biotech
6.10.1 Serum Biotech Corporation Information
6.10.2 Serum Biotech Overview
6.10.3 Serum Biotech Anti-Venom Sales and Revenue in China Market (2016-2021)
6.10.4 Serum Biotech Anti-Venom Product Description
6.10.5 Serum Biotech Recent Developments
6.11 MicroPharm
6.11.1 MicroPharm Corporation Information
6.11.2 MicroPharm Overview
6.11.3 MicroPharm Anti-Venom Sales and Revenue in China Market (2016-2021)
6.11.4 MicroPharm Anti-Venom Product Description
6.11.5 MicroPharm Recent Developments
7 China Anti-Venom Production Capacity, Analysis
7.1 China Anti-Venom Production Capacity, 2016-2027
7.2 Anti-Venom Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Anti-Venom Supply Chain Analysis
9.1 Anti-Venom Industry Value Chain
9.2 Anti-Venom Upstream Market
9.3 Anti-Venom Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Anti-Venom Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
    Table 1. Key Players of Anti-Venom in China Market
    Table 2. Top Anti-Venom Players in China Market, Ranking by Revenue (2019)
    Table 3. China Anti-Venom Revenue by Companies, (US$, Mn), 2016-2021
    Table 4. China Anti-Venom Revenue Share by Companies, 2016-2021
    Table 5. China Anti-Venom Sales by Companies, (K Vials), 2016-2021
    Table 6. China Anti-Venom Sales Share by Companies, 2016-2021
    Table 7. Key Manufacturers Anti-Venom Price (2016-2021) & (USD/Vial)
    Table 8. Manufacturers Anti-Venom Product Type
    Table 9. List of Tier 1 Anti-Venom Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 10. List of Tier 2 and Tier 3 Anti-Venom Companies, Revenue (US$, Mn) in 2020 and Market Share
    Table 11. Major Manufacturers of Polyvalent Anti-Venom
    Table 12. Major Manufacturers of Monovalent Anti-Venom
    Table 13. By Type – China Anti-Venom Revenue, (US$, Mn), 2021 & 2027
    Table 14. By Type - China Anti-Venom Revenue (US$, Mn), 2016-2021
    Table 15. By Type - China Anti-Venom Revenue (US$, Mn), 2022-2027
    Table 16. By Type - China Anti-Venom Sales (K Vials), 2016-2021
    Table 17. By Type - China Anti-Venom Sales (K Vials), 2022-2027
    Table 18. By Application – China Anti-Venom Revenue, (US$, Mn), 2021 VS 2027
    Table 19. By Application - China Anti-Venom Revenue (US$, Mn), 2016-2021
    Table 20. By Application - China Anti-Venom Revenue (US$, Mn), 2022-2027
    Table 21. By Application - China Anti-Venom Sales (K Vials), 2016-2021
    Table 22. By Application - China Anti-Venom Sales (K Vials), 2022-2027
    Table 23. CSL Corporation Information
    Table 24. CSL Description and Major Businesses
    Table 25. CSL Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 26. CSL Anti-Venom Product
    Table 27. CSL Recent Developments
    Table 28. Merck Corporation Information
    Table 29. Merck Description and Major Businesses
    Table 30. Merck Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 31. Merck Anti-Venom Product
    Table 32. Merck Recent Developments
    Table 33. BTG Corporation Information
    Table 34. BTG Description and Major Businesses
    Table 35. BTG Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 36. BTG Anti-Venom Product
    Table 37. BTG Recent Developments
    Table 38. Pfizer Corporation Information
    Table 39. Pfizer Description and Major Businesses
    Table 40. Pfizer Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 41. Pfizer Anti-Venom Product
    Table 42. Pfizer Recent Developments
    Table 43. Haffkine Bio-Pharmaceutical Corporation Information
    Table 44. Haffkine Bio-Pharmaceutical Description and Major Businesses
    Table 45. Haffkine Bio-Pharmaceutical Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 46. Haffkine Bio-Pharmaceutical Anti-Venom Product
    Table 47. Haffkine Bio-Pharmaceutical Recent Developments
    Table 48. Rare Disease Therapeutics Corporation Information
    Table 49. Rare Disease Therapeutics Description and Major Businesses
    Table 50. Rare Disease Therapeutics Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 51. Rare Disease Therapeutics Anti-Venom Product
    Table 52. Rare Disease Therapeutics Recent Developments
    Table 53. Flynn Pharma Corporation Information
    Table 54. Flynn Pharma Description and Major Businesses
    Table 55. Flynn Pharma Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 56. Flynn Pharma Anti-Venom Product
    Table 57. Flynn Pharma Recent Developments
    Table 58. Vins Bioproducts Corporation Information
    Table 59. Vins Bioproducts Description and Major Businesses
    Table 60. Vins Bioproducts Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 61. Vins Bioproducts Anti-Venom Product
    Table 62. Vins Bioproducts Recent Developments
    Table 63. Bharat Serums and Vaccines Corporation Information
    Table 64. Bharat Serums and Vaccines Description and Major Businesses
    Table 65. Bharat Serums and Vaccines Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 66. Bharat Serums and Vaccines Anti-Venom Product
    Table 67. Bharat Serums and Vaccines Recent Developments
    Table 68. Serum Biotech Corporation Information
    Table 69. Serum Biotech Description and Major Businesses
    Table 70. Serum Biotech Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 71. Serum Biotech Anti-Venom Product
    Table 72. Serum Biotech Recent Developments
    Table 73. MicroPharm Corporation Information
    Table 74. MicroPharm Description and Major Businesses
    Table 75. MicroPharm Anti-Venom Sales (K Vials), Revenue (US$, Mn) and Gross Margin (USD/Vial) (2016-2021)
    Table 76. MicroPharm Anti-Venom Product
    Table 77. MicroPharm Recent Developments
    Table 78. Anti-Venom Production Capacity (K Vials) of Key Manufacturers in China Market, 2019-2021 (K Vials)
    Table 79. China Anti-Venom Capacity Market Share of Key Manufacturers, 2019-2021
    Table 80. Anti-Venom Market Opportunities & Trends in China Market
    Table 81. Anti-Venom Market Drivers in China Market
    Table 82. Anti-Venom Market Restraints in China Market
    Table 83. Anti-Venom Raw Materials
    Table 84. Anti-Venom Raw Materials Suppliers in China Market
    Table 85. Typical Anti-Venom Downstream
    Table 86. Anti-Venom Downstream Clients in China Market
    Table 87. Anti-Venom Distributors and Sales Agents in China Market
List of Figures
    Figure 1. Anti-Venom Product Picture
    Figure 2. Anti-Venom Segment by Type
    Figure 3. Anti-Venom Segment by Application
    Figure 4. China Anti-Venom Market Overview: 2020
    Figure 5. China Anti-Venom Market Size: 2021 VS 2027 (US$, Mn)
    Figure 6. China Anti-Venom Revenue, 2016-2027 (US$, Mn)
    Figure 7. Anti-Venom Sales in China Market: 2016-2027 (K Vials)
    Figure 8. The Top 3 and 5 Players Market Share by Anti-Venom Revenue in 2020
    Figure 9. Polyvalent Anti-Venom Product Picture
    Figure 10. Monovalent Anti-Venom Product Picture
    Figure 11. By Type - China Anti-Venom Sales Market Share, 2016-2027
    Figure 12. By Type - China Anti-Venom Revenue Market Share, 2016-2027
    Figure 13. By Type - China Anti-Venom Price (USD/Vial), 2016-2027
    Figure 14. Non-profit Institutions
    Figure 15. Hospitals and Clinic
    Figure 16. By Application - China Anti-Venom Sales Market Share, 2016-2027
    Figure 17. By Application - China Anti-Venom Revenue Market Share, 2016-2027
    Figure 18. By Application - China Anti-Venom Price (USD/Vial), 2016-2027
    Figure 19. CSL Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 20. Merck Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 21. BTG Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 22. Pfizer Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 23. Haffkine Bio-Pharmaceutical Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 24. Rare Disease Therapeutics Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 25. Flynn Pharma Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 26. Vins Bioproducts Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 27. Bharat Serums and Vaccines Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 28. Serum Biotech Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 29. MicroPharm Anti-Venom Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
    Figure 30. China Anti-Venom Production Capacity (K Vials), 2016-2027
    Figure 31. Anti-Venom Industry Value Chain
    Figure 32. Marketing Channels
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3400
This license allows only one user to access the PDF.

Electronic (PDF)
$5100
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$6800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture

RELATED REPORTS

Global and United States Cosmetic Isoparaffins Market Insights Forecast to 2027
Global and United States Cosmetic Isoparaffins Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-29P7682
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Paper Quality Control System QCS Market Insights Forecast to 2027
Global and China Paper Quality Control System(QCS) Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-12Z7843
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and Japan Solid Binder Market Insights Forecast to 2027
Global and Japan Solid Binder Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-23H7493
Tue Nov 30 00:00:00 UTC 2021

Add to Cart

Global and China Tracked Mobile Impact Crushers Market Insights Forecast to 2027
Global and China Tracked Mobile Impact Crushers Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-31S7564
Wed Nov 24 00:00:00 UTC 2021

Add to Cart